Patent · US Expired

Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins

US7507745B2 · kind B2 · utility

5Cited by

2References

18Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Christopher Meade · Bingen, DE
Michel Pairet · Biberach, DE
Michael Pieper · Ingelheim am Rhein, DE

Key dates

Filing date	Jan 18, 2005
Grant date	Mar 24, 2009
Priority date	—
Expiry date	Apr 7, 2025

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel pharmaceutical compositions based on fluorene carboxylic acid ester derived anticholinergics of formula 1and soluble TNF receptor fusion proteins, processes for preparing them and their use in the treatment of respiratory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.